Zomedica Statistics
Total Valuation
Zomedica has a market cap or net worth of 111.22 million. The enterprise value is 60.45 million.
| Market Cap | 111.22M |
| Enterprise Value | 60.45M |
Important Dates
The last earnings date was Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Zomedica has 979.95 million shares outstanding.
| Current Share Class | 979.95M |
| Shares Outstanding | 979.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.82% |
| Owned by Institutions (%) | 0.18% |
| Float | 950.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.78 |
| PB Ratio | 0.93 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.72 |
| EV / Sales | 2.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.71 |
Financial Position
The company has a current ratio of 7.67, with a Debt / Equity ratio of 0.02.
| Current Ratio | 7.67 |
| Quick Ratio | 6.73 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.11 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.41% and return on invested capital (ROIC) is -12.05%.
| Return on Equity (ROE) | -52.41% |
| Return on Assets (ROA) | -11.42% |
| Return on Invested Capital (ROIC) | -12.05% |
| Return on Capital Employed (ROCE) | -25.73% |
| Revenue Per Employee | 193,776 |
| Profits Per Employee | -556,066 |
| Employee Count | 152 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 1.72 |
Taxes
| Income Tax | -285,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.99% in the last 52 weeks. The beta is 1.07, so Zomedica's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | -14.99% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 63.37 |
| Average Volume (20 Days) | 2,365,281 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.18 |
Income Statement
In the last 12 months, Zomedica had revenue of 29.45 million and -84.52 million in losses. Loss per share was -0.09.
| Revenue | 29.45M |
| Gross Profit | 20.06M |
| Operating Income | -31.52M |
| Pretax Income | -84.81M |
| Net Income | -84.52M |
| EBITDA | -23.43M |
| EBIT | -31.52M |
| Loss Per Share | -0.09 |
Balance Sheet
The company has 53.12 million in cash and 2.35 million in debt, giving a net cash position of 50.77 million or 0.05 per share.
| Cash & Cash Equivalents | 53.12M |
| Total Debt | 2.35M |
| Net Cash | 50.77M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 119.69M |
| Book Value Per Share | 0.12 |
| Working Capital | 56.26M |
Cash Flow
In the last 12 months, operating cash flow was -21.28 million and capital expenditures -1.04 million, giving a free cash flow of -22.31 million.
| Operating Cash Flow | -21.28M |
| Capital Expenditures | -1.04M |
| Free Cash Flow | -22.31M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 68.10%, with operating and profit margins of -107.00% and -286.96%.
| Gross Margin | 68.10% |
| Operating Margin | -107.00% |
| Pretax Margin | -287.93% |
| Profit Margin | -286.96% |
| EBITDA Margin | -79.55% |
| EBIT Margin | -107.00% |
| FCF Margin | n/a |
Dividends & Yields
Zomedica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -75.99% |
| FCF Yield | -20.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Zomedica has an Altman Z-Score of 1.09 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.09 |
| Piotroski F-Score | 2 |